Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adoptive Transfer | 2 | 2021 | 825 | 0.990 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2021 | 38 | 0.740 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7876 | 0.670 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 1441 | 0.550 |
Why?
|
| Antigen Presentation | 2 | 2022 | 1251 | 0.540 |
Why?
|
| Cysteine | 1 | 2021 | 897 | 0.520 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 151 | 0.480 |
Why?
|
| Dendritic Cells | 4 | 2022 | 2747 | 0.470 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 806 | 0.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4415 | 0.410 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 4648 | 0.380 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2016 | 977 | 0.350 |
Why?
|
| Autoimmune Diseases | 3 | 2019 | 2257 | 0.350 |
Why?
|
| Mice, Inbred NOD | 4 | 2019 | 1837 | 0.340 |
Why?
|
| Myelin P0 Protein | 1 | 2009 | 15 | 0.320 |
Why?
|
| Myeloid Cells | 1 | 2014 | 839 | 0.320 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2709 | 0.260 |
Why?
|
| Chemokines, CX3C | 1 | 2004 | 12 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 812 | 0.240 |
Why?
|
| Antigens, CD20 | 1 | 2005 | 199 | 0.240 |
Why?
|
| Graft Rejection | 3 | 2014 | 4492 | 0.230 |
Why?
|
| Receptors, HIV | 1 | 2004 | 159 | 0.230 |
Why?
|
| Receptors, IgE | 1 | 2005 | 375 | 0.220 |
Why?
|
| Receptors, Cytokine | 1 | 2004 | 258 | 0.220 |
Why?
|
| Immune Tolerance | 2 | 2019 | 2323 | 0.210 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 716 | 0.210 |
Why?
|
| Cross-Priming | 1 | 2022 | 75 | 0.200 |
Why?
|
| Blood Transfusion | 2 | 2005 | 1309 | 0.190 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 433 | 0.170 |
Why?
|
| Mice | 13 | 2022 | 82029 | 0.170 |
Why?
|
| Transplantation, Homologous | 2 | 2005 | 4833 | 0.170 |
Why?
|
| Extracellular Fluid | 1 | 2021 | 165 | 0.170 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 406 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2433 | 0.160 |
Why?
|
| Proline | 1 | 2021 | 455 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22379 | 0.150 |
Why?
|
| Methionine | 1 | 2021 | 573 | 0.150 |
Why?
|
| Endosomes | 1 | 2021 | 522 | 0.150 |
Why?
|
| Tretinoin | 1 | 2021 | 524 | 0.150 |
Why?
|
| Piperazines | 1 | 2008 | 2554 | 0.150 |
Why?
|
| Glycine | 1 | 2021 | 672 | 0.140 |
Why?
|
| Serine | 1 | 2021 | 831 | 0.140 |
Why?
|
| Ion Channels | 1 | 2021 | 1043 | 0.130 |
Why?
|
| trans-Golgi Network | 1 | 2016 | 33 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2008 | 3048 | 0.130 |
Why?
|
| Animals | 14 | 2022 | 169246 | 0.130 |
Why?
|
| Founder Effect | 1 | 2016 | 185 | 0.130 |
Why?
|
| Lysosomes | 1 | 2021 | 938 | 0.130 |
Why?
|
| Rats, Inbred Lew | 3 | 2005 | 1162 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2021 | 791 | 0.120 |
Why?
|
| Models, Animal | 1 | 2021 | 2120 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2019 | 1140 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 540 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 3447 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14488 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2021 | 2614 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2414 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10474 | 0.100 |
Why?
|
| COS Cells | 1 | 2014 | 1135 | 0.100 |
Why?
|
| Neuropilin-1 | 1 | 2012 | 91 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5703 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2019 | 19015 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 9561 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 822 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 3044 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2019 | 2627 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2014 | 1361 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2021 | 3080 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2008 | 183 | 0.070 |
Why?
|
| Psoriasis | 1 | 2016 | 926 | 0.070 |
Why?
|
| Hybridomas | 1 | 2009 | 444 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3948 | 0.070 |
Why?
|
| Colitis | 1 | 2016 | 1242 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17140 | 0.070 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2005 | 59 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18349 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2009 | 490 | 0.060 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 5505 | 0.060 |
Why?
|
| Base Sequence | 1 | 2016 | 12421 | 0.060 |
Why?
|
| Chemokine CX3CL1 | 1 | 2004 | 62 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1815 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4916 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 1305 | 0.060 |
Why?
|
| Monocytes | 2 | 2019 | 2605 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2005 | 577 | 0.050 |
Why?
|
| Benzamides | 1 | 2008 | 1379 | 0.050 |
Why?
|
| Remission Induction | 1 | 2008 | 2410 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2005 | 563 | 0.050 |
Why?
|
| Epitopes | 1 | 2009 | 2528 | 0.050 |
Why?
|
| Pyrroles | 1 | 2008 | 1124 | 0.050 |
Why?
|
| Multigene Family | 1 | 2005 | 1081 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1989 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2004 | 528 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2005 | 943 | 0.050 |
Why?
|
| Neoplasms | 2 | 2022 | 22371 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13676 | 0.050 |
Why?
|
| Pancreas | 1 | 2008 | 1700 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2005 | 12800 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 587 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2005 | 1092 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2748 | 0.050 |
Why?
|
| Leukocytes | 1 | 2008 | 2035 | 0.040 |
Why?
|
| Indoles | 1 | 2008 | 1836 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 633 | 0.040 |
Why?
|
| Rats | 3 | 2005 | 23760 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 1207 | 0.040 |
Why?
|
| Female | 6 | 2021 | 397192 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 4168 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2065 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2019 | 34 | 0.040 |
Why?
|
| Spleen | 1 | 2005 | 2295 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 859 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 3114 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4580 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2937 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 2843 | 0.040 |
Why?
|
| Cricetulus | 1 | 2019 | 812 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4620 | 0.030 |
Why?
|
| Male | 7 | 2021 | 364719 | 0.030 |
Why?
|
| CHO Cells | 1 | 2019 | 1379 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2005 | 2575 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2004 | 2202 | 0.030 |
Why?
|
| Cytokines | 2 | 2009 | 7453 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6082 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2493 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2019 | 967 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6231 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8128 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2008 | 6430 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13421 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3711 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 17622 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11095 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 445 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 16726 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4937 | 0.020 |
Why?
|
| Macrophages | 1 | 2005 | 5799 | 0.020 |
Why?
|
| Cell Line | 2 | 2019 | 15597 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2022 | 4755 | 0.020 |
Why?
|
| Humans | 6 | 2019 | 768166 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 58 | 0.010 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2004 | 79 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40218 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 250 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 2568 | 0.010 |
Why?
|
| Osteoprotegerin | 1 | 2004 | 179 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2004 | 321 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9263 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11928 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7243 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 3887 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2004 | 3301 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 9384 | 0.000 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_